In a recent study, PKD3 was found to inhibit lysosomal-dependent degradation of the stress-activated chaperone clusterin, thereby promoting clusterin secretion and TNBC tumor growth in a xenograft mouse model (Liu et al., 2021). Here, CLU is linked to neoplasm.